FDA Advisory Committee Shakeup and Implications for Capricor Therapeutics Don't be scared off up by the recent Trump FDA overhaul. The changes are very positive for Capricor Therapeutics moving forward (2025–2028).
What's Going On With Mesoblast Shares Thursday? Mesoblast Limited (
NASDAQ:MESO ) stock is trading higher Thursday after the company announced the U.S. Food and Drug Administration (FDA) approved Ryoncil.
Top-Notch Biotech Mesoblast Skyrockets 29% On Immune Condition Approval The company will soon launch Ryoncil for children at least 2 months old with acute graft versus host disease.
Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges Mesoblast's Ryoncil is now FDA-approved for pediatric SR-aGvHD, marking a milestone in mesenchymal stromal cell therapies in the U.S.
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of NIO Inc. (
NYSE:NIO ) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday We have the biggest pre-market stock movers that investors are going to want to start the trading week with on Monday morning!
